Want to join the conversation?
Biotechnology company $AMGN announced detailed phase 2 results of erenumab drug that showed a significant reduction in monthly migraine days compared with placebo in patients with chronic migraine. This data will be presented at the 5th European Headache and Migraine Trust International Congress (EHMTIC) in Glasgow, Scotland.
$SBUX launched its annual “Starbucks for Life” competition in the U.S. and Canada. The winner of the competition will receive a credit of one drink or food item per day for a duration of 30 years.
$T shares rose 1.8%, as a big boost for the S&P 500. The company said its new streaming television service DirectTV has so far exceeded expectations.
$TXMD flying high.. anyone here to catch..?
$CMG crashing. There seems to be nothing good to read about this company.